Abstract
There are at least four different existing or proposed interpretive criteria for the disk diffusion susceptibility testing of ticarcillin and ticarcillin plus clavulanic acid (T/C). To assess these criteria, 570 gram-negative bacillary isolates were tested for susceptibility to ticarcillin and T/C by both disk diffusion and broth microdilution methods. These included 53 strains of the family Enterobacteriaceae selected for ticarcillin resistance and high-level beta-lactamase production. The broth microdilution test results were more influenced by increased beta-lactamase production than were disk diffusion results. In the absence of published data indicating which of the two standardized test methods better predicts clinical response, we conclude that until such data are available the more conservative National Committee for Clinical Laboratory Standards tentative criteria for tests with members of the Enterobacteriaceae are appropriate. Our data do not support the use of separate T/C interpretive criteria for Pseudomonas spp. and members of the Enterobacteriaceae. The appropriateness of different interpretive criteria needs further evaluation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fuchs P. C., Barry A. L., Thornsberry C., Jones R. N. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrob Agents Chemother. 1984 Mar;25(3):392–394. doi: 10.1128/aac.25.3.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs P. C., Jones R. N., Barry A. L., Thornsberry C. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid. J Clin Microbiol. 1984 Apr;19(4):555–557. doi: 10.1128/jcm.19.4.555-557.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henry D., Skidmore A. G., Ngui-Yen J., Smith A., Smith J. A. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother. 1985 Aug;28(2):259–264. doi: 10.1128/aac.28.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holloway W. J. Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study. Am J Med. 1985 Nov 29;79(5B):168–171. doi: 10.1016/0002-9343(85)90153-6. [DOI] [PubMed] [Google Scholar]
- Paisley J. W., Washington J. A., 2nd Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob Agents Chemother. 1978 Aug;14(2):224–227. doi: 10.1128/aac.14.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanders C. C., Iaconis J. P., Bodey G. P., Samonis G. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother. 1988 Sep;32(9):1365–1369. doi: 10.1128/aac.32.9.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siebert W. T., Kopp P. E. Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections. Am J Med. 1985 Nov 29;79(5B):141–145. doi: 10.1016/0002-9343(85)90148-2. [DOI] [PubMed] [Google Scholar]
- Stobberingh E. E. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin. J Antimicrob Chemother. 1988 Jan;21(1):9–16. doi: 10.1093/jac/21.1.9. [DOI] [PubMed] [Google Scholar]